Skip to main content

CORRECTION article

Front. Genet., 19 June 2020
Sec. Epigenomics and Epigenetics
This article is part of the Research Topic Pioneering the Nexus of Chromatin and Metabolism View all 19 articles

Corrigendum: Exploiting the Circadian Clock for Improved Cancer Therapy: Perspective From a Cell Biologist

\nTia Tyrsett Kuo,
Tia Tyrsett Kuo1,2*Andreas G. Ladurner,,,Andreas G. Ladurner1,2,3,4
  • 1Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany
  • 2Max Planck Institute of Biochemistry, International Max Planck Research School for Molecular and Cellular Life Sciences, Martinsried, Germany
  • 3Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität München, Munich, Germany
  • 4Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität München, Munich, Germany

A Corrigendum on
Exploiting the Circadian Clock for Improved Cancer Therapy: Perspective From a Cell Biologist

by Kuo, T. T., and Ladurner, A. G. (2019). Front. Genet. 10:1210. doi: 10.3389/fgene.2019.01210

In the original article, we neglected to include the funder the “European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement, 675610” to Tia Tyrsett Kuo.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: chronotherapeutic, circadian rhythm, chemotherapy, cancer, precision (stratified) medicine

Citation: Kuo TT and Ladurner AG (2020) Corrigendum: Exploiting the Circadian Clock for Improved Cancer Therapy: Perspective From a Cell Biologist. Front. Genet. 11:601. doi: 10.3389/fgene.2020.00601

Received: 16 May 2020; Accepted: 18 May 2020;
Published: 19 June 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Kuo and Ladurner. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tia Tyrsett Kuo, dGlhLnR5cnNldHQmI3gwMDA0MDtibWMubWVkLmxtdS5kZQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.